- Warner Lambert, Boots ally to co-promote Lopid, Manoplax
- American Home Products to acquire Cyanamid for $9.7 billion
- European co-promo rts to diabetes drug to Glaxo from Sankyo
- CoCensys and Warner-Lambert to codevelop CNS drugs
- Ribozyme collaborates with Warner-Lambert on therapeutics
- RiboGene to screen Warner-Lambert library for anti-infectives
- Pfizer to co-promote W-L lipid drug atorvastatin
- Warner-Lambert and Sankyo form 50/50 US joint venture
- Upjohn, Pharmacia in $6.5b tax-free "merger of equals"
Ask The Analyst
Please Note: Click here for more information on the Ask the Analyst service.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.